Orexo: Zubsolv Rx data – November

Research Update

2017-12-08

10:12

The market share for Zubsolv in November (four weeks rolling average) was at 4.97% (prescriptions) and 5.19% (quantity). This was pretty much unchanged compared to the market share in October. The underlying market grew y/y by 8.2% (prescriptions) and of 9.3% (quantity).

KP

Klas Palin

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.